Discontinued — last reported Q4 '25
West Pharmaceutical Services Other operating expenses increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$400.00K to $0.00. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising operational complexity or inefficient cost management, while a decrease suggests improved expense control or reduced non-core operational activity.
This metric represents miscellaneous operating costs that do not fall under primary expense categories such as cost of g...
Peers in the energy infrastructure sector typically report this as a small percentage of total operating expenses; significant deviations often warrant investigation into accounting reclassifications.
other_operating_expenses| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.50M | -$700.00K | $0.00 | $100.00K | $300.00K | -$400.00K | -$300.00K | $400.00K | -$300.00K | $0.00 | -$600.00K | -$400.00K | -$300.00K | -$300.00K | $0.00 |
| QoQ Change | — | -146.7% | +100.0% | — | +200.0% | -233.3% | +25.0% | +233.3% | -175.0% | +100.0% | — | +33.3% | +25.0% | +0.0% | +100.0% |
| YoY Change | — | — | — | -93.3% | +142.9% | — | -400.0% | +33.3% | +25.0% | +100.0% | -250.0% | -33.3% | — | +50.0% | +100.0% |